Pfizer GMG Competitive Grant Program: Quantifying the Socio-Economic Burden of Disease for Dermatology Patients and Caregivers

Closing Date: 28/04/2022

Funding to support projects that focus on quantifying the socio-economic burden of disease in atopic dermatitis, and/or alopecia areata patients and their caregivers, with a goal of understanding if the current level of healthcare system resources matches the patient need.

Pfizer Inc. is an American multinational pharmaceutical corporation founded in 1849 and headquartered in New York City. It is one of the world’s largest pharmaceutical companies.

Pfizer Global Medical Grants (GMG) support the global healthcare community’s independent initiatives (research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Within the framework of the ‘Quantifying the Socio-Economic Burden of Disease for Dermatology Patients and Caregivers’ Request for Proposals, funding is available to support projects that focus on quantifying the socio-economic burden of disease in atopic dermatitis, and/or alopecia areata patients and their caregivers, with a goal of understanding if the current level of healthcare system resources matches the patient need.

  • The socio-economic burden includes but is not limited to such costs as:
    • Time away from work or school for the patient or their caregivers.
    • Out of pocket expenditures for treatment or services.
    • Use of mental health services or treatments/absenteeism due to disease-related anxiety or depression.
    • Loss of academic or career opportunities.
    • Other quality-of-life impacts.
  • To understand and address this gap, Pfizer seeks to support research efforts that will quantify the burden of disease for atopic dermatitis and/or alopecia areata and advance the efforts of patient advocacy groups that hope to develop resources to address the burden.
Funding body Pfizer Inc.
Maximum value 75,000 USD
Reference ID S23506
Category Medical Research

Fund or call Fund